Citadel Advisors
PASW

Citadel Advisors’s Ping An Biomedical PASW Stock Holding History

Citadel Advisors’s Portfolio PASW Stock Details PASW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19K Buy
+114,177
New +$18.4K ﹤0.01% 13413
2026
Q1 		– Sell
-22,886
Closed -$11.5K – 14762
2025
Q4 		$11.5K Buy
22,886
+593
+3% +$396 ﹤0.01% 12424
2025
Q3 		$27.6K Buy
+22,293
New +$32.9K ﹤0.01% 12421

Other funds holding PASW

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Citadel Advisors's PASW Position: Q2 2026 in Review

Citadel Advisors opened a new position in Ping An Biomedical (PASW) in Q2 2026: 114,177 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #13413 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PASW as recently as Q4 2025.

Citadel Advisors first reported a position in PASW in Q3 2025 and has held it in 3 quarters since. The position peaked at $27.6K in Q3 2025. 4 funds tracked by Wall St. Rank hold PASW as of Q2 2026.

  • Citadel Advisors held 114,177 shares of Ping An Biomedical worth $19K as of Q2 2026.
  • Ping An Biomedical was a new Citadel Advisors position in Q2 2026.
  • Ping An Biomedical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13413 holding.
  • Citadel Advisors first reported a position in Ping An Biomedical in Q3 2025 and has held it in 3 quarters since.
  • Citadel Advisors's Ping An Biomedical position peaked at $27.6K in Q3 2025.
  • 4 funds tracked by Wall St. Rank held Ping An Biomedical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.